Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case seriesBaptiste Hoellinger, Yvon Ruch, Célestine Simand et al.|Clinical Microbiology and Infection|2022Cited by 25
Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case seriesMarc Scherlinger, Vincent Gies, Benoît Nespola et al.|Annals of the Rheumatic Diseases|2026Cited by 5
POS1121 THE USE OF THE CD3/CD19 T CELL ENGAGER BLINATUMOMAB IN SEVERE SYSTEMIC SCLEROSIS: A CASE SERIESM. Scherlinger, J. Sibilia, Yannick Dieudonné et al.|Annals of the Rheumatic Diseases|2025Cited by 3